Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs

NARecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

October 14, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
AphakiaPresbyopia
Interventions
DEVICE

Clareon PanOptix Pro/Pro Toric Trifocal IOL

Intraocular lens (IOL) placed into the lens capsule of the eye during cataract surgery. IOLs are implantable medical devices intended for long-term use over the lifetime of the pseudophakic subject.

PROCEDURE

Phacoemulsification

Cataract surgery technique that uses ultrasound to break up and remove the clouded lens, allowing for IOL implantation.

Trial Locations (5)

29464

RECRUITING

Carolina Eyecare Physicians LLC, Mt. Pleasant

64154

RECRUITING

Moyes Eye Center, Kansas City

77008

RECRUITING

Houston Eye Associates, Houston

84107

RECRUITING

The Eye Institute of Utah, Salt Lake City

90505

RECRUITING

Wolstan & Goldberg Eye Associates, Torrance

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT07161635 - Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs | Biotech Hunter | Biotech Hunter